These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 12722311

  • 1. [Quinolone].
    Niki Y, Kobashi Y.
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():750-5. PubMed ID: 12722311
    [No Abstract] [Full Text] [Related]

  • 2. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection.
    Ruiz J.
    J Antimicrob Chemother; 2003 May; 51(5):1109-17. PubMed ID: 12697644
    [Abstract] [Full Text] [Related]

  • 3. [Quinolone].
    Sato K, Tanaka M.
    Nihon Rinsho; 2003 Mar; 61 Suppl 3():227-33. PubMed ID: 12717976
    [No Abstract] [Full Text] [Related]

  • 4. Mechanisms of quinolone action and microbial response.
    Hawkey PM.
    J Antimicrob Chemother; 2003 May; 51 Suppl 1():29-35. PubMed ID: 12702701
    [Abstract] [Full Text] [Related]

  • 5. Dual-targeting properties of the 3-aminopyrrolidyl quinolones, DC-159a and sitafloxacin, against DNA gyrase and topoisomerase IV: contribution to reducing in vitro emergence of quinolone-resistant Streptococcus pneumoniae.
    Okumura R, Hirata T, Onodera Y, Hoshino K, Otani T, Yamamoto T.
    J Antimicrob Chemother; 2008 Jul; 62(1):98-104. PubMed ID: 18390884
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mechanism of action of and resistance to quinolones.
    Bearden DT, Danziger LH.
    Pharmacotherapy; 2001 Oct; 21(10 Pt 2):224S-232S. PubMed ID: 11642689
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Quinolone resistance mechanisms in pneumococci.
    Eliopoulos GM.
    Clin Infect Dis; 2004 May 15; 38 Suppl 4():S350-6. PubMed ID: 15127369
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Quinolones. Gyrase inhibitors].
    Höffler D.
    Internist (Berl); 1994 May 15; 35(5):484-9. PubMed ID: 8021119
    [No Abstract] [Full Text] [Related]

  • 13. Target preference of 15 quinolones against Staphylococcus aureus, based on antibacterial activities and target inhibition.
    Takei M, Fukuda H, Kishii R, Hosaka M.
    Antimicrob Agents Chemother; 2001 Dec 15; 45(12):3544-7. PubMed ID: 11709337
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. An unusually high level of quinolone resistance associated with type II topoisomerase mutations in quinolone resistance-determining regions of Aeromonas caviae isolated from diarrhoeal patients.
    Sinha S, Chattopadhyay S, Bhattacharya SK, Nair GB, Ramamurthy T.
    Res Microbiol; 2004 Dec 15; 155(10):827-9. PubMed ID: 15567276
    [Abstract] [Full Text] [Related]

  • 17. Reduction of the fitness burden of quinolone resistance in Pseudomonas aeruginosa.
    Kugelberg E, Löfmark S, Wretlind B, Andersson DI.
    J Antimicrob Chemother; 2005 Jan 15; 55(1):22-30. PubMed ID: 15574475
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and antibacterial activity of a novel series of potent DNA gyrase inhibitors. Pyrazole derivatives.
    Tanitame A, Oyamada Y, Ofuji K, Fujimoto M, Iwai N, Hiyama Y, Suzuki K, Ito H, Terauchi H, Kawasaki M, Nagai K, Wachi M, Yamagishi J.
    J Med Chem; 2004 Jul 01; 47(14):3693-6. PubMed ID: 15214796
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The interaction of drugs with DNA gyrase: a model for the molecular basis of quinolone action.
    Heddle JG, Barnard FM, Wentzell LM, Maxwell A.
    Nucleosides Nucleotides Nucleic Acids; 2000 Aug 01; 19(8):1249-64. PubMed ID: 11097055
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.